List of Tables
Table 1. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-VEGF Drugs for the Treatment of Wet AMD Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-VEGF Drugs for the Treatment of Wet AMD, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-VEGF Drugs for the Treatment of Wet AMD, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-VEGF Drugs for the Treatment of Wet AMD, Product Type & Application
Table 12. Global Key Manufacturers of Anti-VEGF Drugs for the Treatment of Wet AMD, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-VEGF Drugs for the Treatment of Wet AMD by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-VEGF Drugs for the Treatment of Wet AMD as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Region (2019-2024) & (K Dose)
Table 18. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Region (2019-2024)
Table 19. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Region (2025-2030) & (K Dose)
Table 20. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Region (2025-2030)
Table 21. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2019-2024) & (K Dose)
Table 27. North America Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2025-2030) & (K Dose)
Table 28. North America Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Anti-VEGF Drugs for the Treatment of Wet AMD Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Anti-VEGF Drugs for the Treatment of Wet AMD Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose) by Type (2019-2024)
Table 51. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose) by Type (2025-2030)
Table 52. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Type (2019-2024)
Table 53. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Type (2025-2030)
Table 54. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-VEGF Drugs for the Treatment of Wet AMD Price (US$/Dose) by Type (2019-2024)
Table 59. Global Anti-VEGF Drugs for the Treatment of Wet AMD Price (US$/Dose) by Type (2025-2030)
Table 60. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose) by Application (2019-2024)
Table 61. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose) by Application (2025-2030)
Table 62. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Application (2019-2024)
Table 63. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Application (2025-2030)
Table 64. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-VEGF Drugs for the Treatment of Wet AMD Price (US$/Dose) by Application (2019-2024)
Table 69. Global Anti-VEGF Drugs for the Treatment of Wet AMD Price (US$/Dose) by Application (2025-2030)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Roche Anti-VEGF Drugs for the Treatment of Wet AMD Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Novartis Anti-VEGF Drugs for the Treatment of Wet AMD Product
Table 79. Novartis Recent Developments/Updates
Table 80. Coherus BioSciences Company Information
Table 81. Coherus BioSciences Description and Business Overview
Table 82. Coherus BioSciences Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Coherus BioSciences Anti-VEGF Drugs for the Treatment of Wet AMD Product
Table 84. Coherus BioSciences Recent Developments/Updates
Table 85. Regeneron Pharmaceuticals Company Information
Table 86. Regeneron Pharmaceuticals Description and Business Overview
Table 87. Regeneron Pharmaceuticals Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Regeneron Pharmaceuticals Anti-VEGF Drugs for the Treatment of Wet AMD Product
Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
Table 90. Samsung Bioepis Company Information
Table 91. Samsung Bioepis Description and Business Overview
Table 92. Samsung Bioepis Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Samsung Bioepis Anti-VEGF Drugs for the Treatment of Wet AMD Product
Table 94. Samsung Bioepis Recent Developments/Updates
Table 95. Biocon Biologics Company Information
Table 96. Biocon Biologics Description and Business Overview
Table 97. Biocon Biologics Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Biocon Biologics Anti-VEGF Drugs for the Treatment of Wet AMD Product
Table 99. Biocon Biologics Recent Developments/Updates
Table 100. Chengdu Kanghong Pharmaceutical Company Information
Table 101. Chengdu Kanghong Pharmaceutical Description and Business Overview
Table 102. Chengdu Kanghong Pharmaceutical Anti-VEGF Drugs for the Treatment of Wet AMD Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Chengdu Kanghong Pharmaceutical Anti-VEGF Drugs for the Treatment of Wet AMD Product
Table 104. Chengdu Kanghong Pharmaceutical Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Anti-VEGF Drugs for the Treatment of Wet AMD Distributors List
Table 108. Anti-VEGF Drugs for the Treatment of Wet AMD Customers List
Table 109. Anti-VEGF Drugs for the Treatment of Wet AMD Market Trends
Table 110. Anti-VEGF Drugs for the Treatment of Wet AMD Market Drivers
Table 111. Anti-VEGF Drugs for the Treatment of Wet AMD Market Challenges
Table 112. Anti-VEGF Drugs for the Treatment of Wet AMD Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-VEGF Drugs for the Treatment of Wet AMD
Figure 2. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Share by Type: 2023 & 2030
Figure 4. Single target Drugs Product Picture
Figure 5. Multi-target Drugs Product Picture
Figure 6. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Share by Application: 2023 & 2030
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Size (2019-2030) & (US$ Million)
Figure 13. Global Anti-VEGF Drugs for the Treatment of Wet AMD Sales (2019-2030) & (K Dose)
Figure 14. Global Anti-VEGF Drugs for the Treatment of Wet AMD Average Price (US$/Dose) & (2019-2030)
Figure 15. Anti-VEGF Drugs for the Treatment of Wet AMD Report Years Considered
Figure 16. Anti-VEGF Drugs for the Treatment of Wet AMD Sales Share by Manufacturers in 2023
Figure 17. Global Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Anti-VEGF Drugs for the Treatment of Wet AMD Players: Market Share by Revenue in Anti-VEGF Drugs for the Treatment of Wet AMD in 2023
Figure 19. Anti-VEGF Drugs for the Treatment of Wet AMD Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Anti-VEGF Drugs for the Treatment of Wet AMD Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Country (2019-2030)
Figure 22. North America Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Country (2019-2030)
Figure 23. United States Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Country (2019-2030)
Figure 26. Europe Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Country (2019-2030)
Figure 27. Germany Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Region (2019-2030)
Figure 34. China Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Country (2019-2030)
Figure 42. Mexico Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Anti-VEGF Drugs for the Treatment of Wet AMD Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Anti-VEGF Drugs for the Treatment of Wet AMD Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Anti-VEGF Drugs for the Treatment of Wet AMD by Type (2019-2030)
Figure 52. Global Revenue Market Share of Anti-VEGF Drugs for the Treatment of Wet AMD by Type (2019-2030)
Figure 53. Global Anti-VEGF Drugs for the Treatment of Wet AMD Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Anti-VEGF Drugs for the Treatment of Wet AMD by Application (2019-2030)
Figure 55. Global Revenue Market Share of Anti-VEGF Drugs for the Treatment of Wet AMD by Application (2019-2030)
Figure 56. Global Anti-VEGF Drugs for the Treatment of Wet AMD Price (US$/Dose) by Application (2019-2030)
Figure 57. Anti-VEGF Drugs for the Treatment of Wet AMD Value Chain
Figure 58. Anti-VEGF Drugs for the Treatment of Wet AMD Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
